WHO Declares India Free of Lymphatic Filariasis
The World Health Organization (WHO) has officially certified India as having eliminated Lymphatic Filariasis (LF) as a public health problem, marking a significant milestone in global health. This achievement is the culmination of decades of sustained efforts, including nationwide Mass Drug Administration campaigns and comprehensive surveillance under the National Programme for Elimination of Lymphatic Filariasis (NPELF). India, once home to a substantial portion of the global LF burden, has demonstrated its capability in tackling major public health challenges.
2-Minute Summary (TL;DR)
- The World Health Organization (WHO) has certified India as having eliminated Lymphatic Filariasis (LF) as a public health problem.
- Lymphatic Filariasis, commonly known as Elephantiasis, is a parasitic disease caused by filarial worms transmitted by mosquitoes, primarily Culex quinquefasciatus.
- India's elimination efforts were spearheaded by the National Programme for Elimination of Lymphatic Filariasis (NPELF), launched in 2004.
- Key strategies included Mass Drug Administration (MDA) using drugs like Diethylcarbamazine (DEC) and Albendazole, and later Triple Drug Therapy (IDA).
- Mission Zero LF was a crucial initiative that synchronized drug distribution across endemic districts to accelerate elimination.
- India accounted for nearly 40% of the global LF burden before this achievement, making it a significant global health milestone.
- The elimination was confirmed through Transmission Assessment Surveys (TAS), which verify the interruption of transmission.
- Post-elimination, India will continue a 5-year surveillance plan to prevent any resurgence and focus on Morbidity Management and Disability Prevention (MMDP).
- This success reinforces India's robust public health infrastructure, following previous eliminations of diseases like Polio (2014) and Smallpox (1977).
Why In News
The World Health Organization (WHO) recently certified India as having eliminated Lymphatic Filariasis as a public health problem, marking a monumental achievement in the nation's public health journey. This declaration follows decades of concerted efforts, including extensive Mass Drug Administration campaigns and robust surveillance, positioning India as a global leader in disease eradication. The news highlights the success of the National Programme for Elimination of Lymphatic Filariasis (NPELF) and its coordinated initiatives.
Syllabus Connection
This news connects to understanding public health policies, disease elimination strategies, the role of international organizations like WHO, and the impact of large-scale health interventions on national development and global health goals.
Prelims vs Mains — What to Focus On
| Aspect | Prelims | Mains |
|---|---|---|
| What is Lymphatic Filariasis? | Parasitic disease causing severe swelling, transmitted by mosquitoes. | Discuss socio-economic impact and challenges in managing chronic disability. |
| Key Intervention Strategy | Mass Drug Administration (MDA) with DEC and Albendazole. | Analyze effectiveness and challenges of MDA in diverse populations. |
| India's Elimination Initiative | National Programme for Elimination of Lymphatic Filariasis (NPELF), Mission Zero LF. | Evaluate multi-sectoral approach and community participation in NPELF. |
| Role of WHO | Certified India LF-free; supports global elimination goals. | Examine WHO's framework for disease elimination and its collaborative role. |
| Significance for India | Major public health achievement, reduces disease burden and poverty. | Reflects robust public health infrastructure and potential for future eradications. |
How This Topic is Tested in Competitive Exams
| Exam | Frequency | Approx. Marks | What Gets Asked |
|---|---|---|---|
| SSC (CGL / CHSL / MTS) | Medium | 2–4 | Miscellaneous GK including appointments, books, summits, and records appears in SSC. |
| UPSC / State PCS | Low | 2–5 | UPSC focuses on depth, not breadth. General items are tested only when they have policy relevance. |
| State PCS / PSC | Medium | 3–5 | Miscellaneous GK is tested across all state exam categories. |
Key Facts to Remember: WHO Declares India Free of Lymphatic Filariasis
- The World Health Organization (WHO) has certified India as having eliminated Lymphatic Filariasis (LF) as a public health problem.
- Lymphatic Filariasis, commonly known as Elephantiasis, is a parasitic disease caused by filarial worms transmitted by mosquitoes, primarily Culex quinquefasciatus.
- India's elimination efforts were spearheaded by the National Programme for Elimination of Lymphatic Filariasis (NPELF), launched in 2004.
- Key strategies included Mass Drug Administration (MDA) using drugs like Diethylcarbamazine (DEC) and Albendazole, and later Triple Drug Therapy (IDA).
- Mission Zero LF was a crucial initiative that synchronized drug distribution across endemic districts to accelerate elimination.
- India accounted for nearly 40% of the global LF burden before this achievement, making it a significant global health milestone.
- The elimination was confirmed through Transmission Assessment Surveys (TAS), which verify the interruption of transmission.
- Post-elimination, India will continue a 5-year surveillance plan to prevent any resurgence and focus on Morbidity Management and Disability Prevention (MMDP).
- This success reinforces India's robust public health infrastructure, following previous eliminations of diseases like Polio (2014) and Smallpox (1977).
Practice Questions
Q1. Which of the following mosquitoes is the primary vector for transmitting Lymphatic Filariasis in India?
- Anopheles stephensi
- Aedes aegypti
- Culex quinquefasciatus
- Mansonia uniformis
Explanation: Lymphatic Filariasis is primarily transmitted by the Culex quinquefasciatus mosquito in India. Anopheles mosquitoes are known vectors for malaria, while Aedes aegypti transmits dengue and chikungunya.
Q2. What is the common name for Lymphatic Filariasis, characterized by severe swelling and thickening of the skin?
- Kala-azar
- Elephantiasis
- Dengue
- Chikungunya
Explanation: Lymphatic Filariasis is commonly known as Elephantiasis due to the severe swelling and thickening of the skin and underlying tissues it causes, particularly in the limbs and genitals. Kala-azar is a different parasitic disease.
Q3. Which of the following drug combinations is part of the Triple Drug Therapy (IDA) used in India's Lymphatic Filariasis elimination program?
- Paracetamol, Aspirin, Ibuprofen
- Ivermectin, Diethylcarbamazine, Albendazole
- Chloroquine, Primaquine, Artemisinin
- Rifampicin, Isoniazid, Pyrazinamide
Explanation: The Triple Drug Therapy (IDA) for Lymphatic Filariasis consists of Ivermectin, Diethylcarbamazine (DEC), and Albendazole. This combination was introduced to enhance the effectiveness of Mass Drug Administration.
Q4. Which global organization certified India as having eliminated Lymphatic Filariasis as a public health problem?
- UNICEF
- World Bank
- World Health Organization (WHO)
- Doctors Without Borders (MSF)
Explanation: The World Health Organization (WHO) is the specialized agency of the United Nations responsible for international public health. It provides certifications for disease elimination based on stringent criteria and assessments.
Q5. What was the primary strategy employed in India's National Programme for Elimination of Lymphatic Filariasis (NPELF) to interrupt disease transmission?
- Extensive vaccination campaigns
- Mass Drug Administration (MDA)
- Surgical intervention for all cases
- Complete mosquito eradication
Explanation: The primary strategy for interrupting transmission in the NPELF was Mass Drug Administration (MDA), where anti-filarial drugs were administered to entire populations in endemic areas. While vector control is part of the strategy, complete mosquito eradication is generally not feasible or the primary method for LF elimination.
How to Prepare Current Affairs for Government Exams — WHO Declares India Free of Lymphatic Filariasis
For general current affairs, read the PIB (Press Information Bureau) daily digest. It covers government announcements that directly map to exam questions.
Maintain a 'Monthly Top 50' list — the 50 most important facts from the month. Revise this before every mock test.
Focus on news from the last 6–8 months before your exam date. Older news rarely appears unless it was a landmark event.
Related Current Affairs
Test Your Knowledge on Today's Current Affairs
10 questions · 10 minutes · Based on today's GK updates. See how prepared you really are.
Start Daily Quiz